Building Resilient Pharmaceutical Supply Chains for Accessible Medicines

<div class="ag87-crtemvc-hsbk"><div class="css-vsf5of"><p class="carina-rte-public-DraftStyleDefault-block"><span style="color: rgb(29,28,29);">Due to a reliance on agricultural-based starting materials and active ingredients, the pharmaceutical industry has long struggled with disruptions from climate crises, pests and disease, global transportation logistics, and geopolitical events. These types of disruptions regularly trigger shortages of essential medicines, which ultimately has implications for patients in need. Synthetic biology is poised to help the pharmaceutical industry overcome its current supply chain challenges and limitations to produce active pharmaceutical ingredients (APIs) and key starting materials (KSMs) in a more efficient, reliable, and consistent approach. Join this breakout session to hear from a panel of experts from across the pharmaceutical supply chain about the scope of the current challenge the industry faces and how synthetic biology is bringing forth solutions that are ready to scale now.</span></p></div></div>